Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
53 hedge funds and large institutions have $16.2M invested in Applied Genetic Technologies Corporation in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 11 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 55 → 53 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
28% less capital invested
Capital invested by funds: $22.4M → $16.2M (-$6.25M)
76% less call options, than puts
Call options by funds: $145K | Put options by funds: $616K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$4.29M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.76M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$452K |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$445K |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$294K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
-$716K |
| 2 |
Morgan Stanley
New York
|
-$381K |
| 3 |
Two Sigma Advisers
New York
|
-$313K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$278K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$262K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Two Sigma Investments
New York
| – | -$166K | -87,374 | Closed |
|
|
XT
52
XTX Topco
George Town,
Cayman Islands
| – | -$33K | -17,606 | Closed |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| – | -$32K | -16,793 | Closed |
|
54
Squarepoint
New York
| – | -$29K | -15,288 | Closed |
|
|
TSS
55
Two Sigma Securities
New York
| – | -$29K | -15,282 | Closed |
|
56
Charles Schwab
San Francisco,
California
| – | -$25K | -12,820 | Closed |
|
|
WMSA
57
Weiss Multi-Strategy Advisers
New York
| – | -$20K | -10,607 | Closed |
|
58
Simplex Trading
Chicago,
Illinois
| – | -$8.33K | -4,586 | Closed |
|
59
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4.71K | -2,591 | -99% |
|
|
EVM
60
Eaton Vance Management
Boston,
Massachusetts
| – | -$2K | -1,000 | Closed |
|
|
SPIA
61
Steward Partners Investment Advisory
New York
| – | +$25 | +14 | +4% |
|
62
Citigroup
New York
| – | +$818 | +450 | New |
|
AGTC Hedge Fund Activity: Q1 2022 in Review
53 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2022, worth a combined $16.2M — down 28% from $22.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of AGTC and 9 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 15 added.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $4.29M. The largest seller was Altrinsic Global Advisors, exiting entirely with an estimated $716K sold.
- 53 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2022, down from 55 in Q4 2021.
- Funds reported $16.2M of Applied Genetic Technologies Corporation stock for Q1 2022, down 28% quarter-over-quarter.
- 9 funds opened new Applied Genetic Technologies Corporation positions in Q1 2022 and 11 closed out, a net change of -2 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q1 2022 was Cantor Fitzgerald, an estimated $4.29M added.
- The largest Applied Genetic Technologies Corporation seller in Q1 2022 was Altrinsic Global Advisors, an estimated $716K sold.
Based on aggregated 13F filings for Q1 2022.